10,000 Expected at Global Nutritional Technology Developer’s Seoul
Gathering
SEOUL, South Korea--(BUSINESS WIRE)--Oct. 22, 2015--
Mannatech,
Incorporated (NASDAQ: MTEX),
the founder of the M5M℠
(Mission 5 Million℠) Foundation, the pioneer of
nutritional glycobiology and the global innovator of naturally sourced
supplements based on Real
Food Technology® solutions, is expecting more than 10,000
attendees at its annual Asia MannaFest℠ event at Jamsil Olympic Park on
October 31. As Mannatech’s largest global event, thousands will gather
to share their boundless enthusiasm for the wellness and entrepreneurial
opportunities the company offers throughout Asia.
Mannatech’s growing presence in Asia will be on full display as the
event brings together Mannatech independent sales Associates and leaders
from numerous countries and cities, including Korea, Hong Kong, Japan,
Taiwan, Singapore and South Africa. The sales Associates will share
recognition, acknowledge business builders and celebrate a year’s worth
of success. Asia is leading Mannatech’s global expansion as the region’s
increasingly prosperous population makes health, wellness, nutrition and
fitness a priority.
“Asia MannaFest will be a life-changing event for many of the thousands
who attend,” said Mannatech CEO and President Al Bala. “Our operations
in Asia, specifically in Korea, are at the heart of Mannatech’s global
success. Our teams in Asia continue to set a magnificent pace for
innovation and professionalism for Mannatech and all other direct sales
companies.”
Asia MannaFest will be hosted by Mannatech Korea and led by Patrick
Park, Mannatech’s Regional President of Asia. Park has been instrumental
in Mannatech’s rapid growth in the region, and will serve as the dynamic
master of ceremonies at the Asia MannaFest event.
“We are extremely proud of the amazing effort our sales Associates
demonstrate on a daily basis, and this event is just a small indication
of the excitement Mannatech is generating in Asia,” said Park. “Asia
MannaFest is an event unlike any other. It is proof that Mannatech is a
force in this region because of its ability to attract thousands of
independent sales Associates, who represent hundreds of thousands of
satisfied customers whose lives have been impacted by Mannatech’s
products.”
As an extra highlight, Mannatech will be launching its new product,
Cognitate™, exclusively in Korea at Asia MannaFest. Cognitate is a brain
health supplement designed to help improve cognitive ability. It helps
to improve memory and protects against age-related cognitive decline.*
Cognitate is designed for Korean families with older members, busy
parents, business professionals and high-achieving students.
In addition, for the first time ever, Mannatech’s entire Board of
Directors will make the trip to Asia to tour Mannatech’s Asia Regional
Offices, underscoring the Asia-Pacific market’s prominent role in the
company’s international expansion.
Asia MannaFest special guests and speakers include Al Bala; Global
Wellness Director, Steve Nugent; and M5M℠ Foundation Executive Director,
Sarah Bowen.
Registration and General Sessions will begin on Saturday, October 31 at
9 a.m. in the Exhibition Zone of the SK Handball Stadium in Olympic Park.
The event will kick off on Friday, October 30 at 5 p.m. with a special
dinner party to honor the accomplishments of select Mannatech Asia sales
Associates.
For more information, please visit http://www.mannatech.co.kr/amf2015/en/.
About Mannatech
Mannatech, Incorporated, develops high-quality health, weight and
fitness, and skin care products that are based on the solid foundation
of nutritional science and development standards. Mannatech is dedicated
to its platform of Social Entrepreneurship based on the foundation of
promoting, aiding and optimizing childhood nutrition where it is needed
most around the world. Mannatech’s proprietary products are available
through independent sales associates around the globe including the
United States, Canada, South Africa, Australia, New Zealand, Austria,
Denmark, Germany, Norway, Sweden, the Netherlands, the United Kingdom,
Japan, Taiwan, Singapore, Estonia, Finland, the Republic of Ireland,
Czech Republic, the Republic of Korea, Mexico, Namibia, Spain and Hong
Kong. For more information, visit Mannatech.com.
Please note: This release contains “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as amended,
and the Private Securities Litigation Reform Act of 1995. These
forward-looking statements generally can be identified by use of phrases
or terminology such as “intend” or other similar words or the negative
of such terminology. Similarly, descriptions of Mannatech’s objectives,
strategies, plans, goals or targets contained herein are also considered
forward-looking statements. Mannatech believes this release should be
read in conjunction with all of its filings with the United States
Securities and Exchange Commission and cautions its readers that these
forward-looking statements are subject to certain events, risks,
uncertainties and other factors. Some of these factors include, among
others, Mannatech’s inability to attract and retain associates and
members, increases in competition, litigation, regulatory changes and
its planned growth into new international markets. Although Mannatech
believes that the expectations, statements and assumptions reflected in
these forward-looking statements are reasonable, it cautions readers to
always consider all of the risk factors and any other cautionary
statements carefully in evaluating each forward-looking statement in
this release, as well as those set forth in its latest Annual Report on
Form 10-K and Quarterly Report on Form 10-Q, and other filings filed
with the United States Securities and Exchange Commission, including its
current reports on Form 8-K. All of the forward-looking statements
contained herein speak only as of the date of this release.
*This statement has not been evaluated by the Food and Drug
Administration. This product is not intended to diagnose, treat, cure or
prevent any disease.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151022005981/en/
Source: Mannatech, Incorporated
Mannatech, Incorporated
Kalyn Ballard, 972-471-7245
pr@mannatech.com